Documentation
How to read a peptide certificate of analysis
A field by field walkthrough of a peptide certificate of analysis, and what each result can and cannot establish.
Research Peptides Labs editorial team. Published September 22, 2026. About 5 minutes.
For laboratory research use only. Not for human or veterinary use, consumption, diagnostic use, or therapeutic application.
What a certificate of analysis is
A certificate of analysis lists the tests run on one sample, the method used for each test, the result, and the acceptance criterion the result is compared against. It describes the sample that was tested and nothing else, so the whole value of the document depends on which sample that was and how clearly the paperwork says so.
The structure comes from the way analytical specifications are written. A specification is a list of tests, references to the analytical procedures used, and the acceptance criteria those procedures are judged against 1. A certificate of analysis is the filled-in version of that list for a single batch of material. Read it in that order and the document stops looking like a wall of numbers.
Two documents can carry the same headline number and mean different things. One may report a chromatographic percentage on an unnamed method with no batch reference. The other may name the procedure, the batch and the date. The second is a record. The first is a figure without a subject.
Field by field, and what each field settles
The table below walks the fields that appear on most peptide reports. The third column matters more than the second, because most misreadings come from treating one measurement as an answer to a question it was never asked.
| Field on the document | What it establishes | What it does not establish |
|---|---|---|
| Product name and sequence | Which molecule was intended | That any particular vial matches |
| Lot or batch identifier | Which material the results belong to | Anything about a different lot |
| Test date | When the measurement was made | The present condition of the material |
| Appearance | The gross physical state of the sample | Chemical identity |
| Identity by mass spectrometry | That the observed molecular mass matches the expected mass | How much peptide is present |
| Purity by HPLC, area percent | The share of the detected signal belonging to the main peak | Net peptide content by weight |
| Net peptide content | How much of the sample mass is peptide | The purity of that peptide |
| Water or residual solvent | Non-peptide mass present in the sample | Peptide quality |
| Method reference | Which procedure produced the result | That the procedure was followed correctly here |
Identity and purity are the two entries most often read as one. Mass spectrometry answers the question of which molecule the main component is 6. Chromatographic purity answers how much of the detected signal that component accounts for 4. Neither answers how much peptide is in the container by weight, which is a separate measurement made by amino acid analysis or an equivalent quantitative method 3.
Why the method name matters as much as the number
A result carries meaning only alongside the procedure that produced it, which is the reason analytical procedures are validated and named in the first place 2. Two laboratories reporting purity on different gradients, different columns and different detection wavelengths can both be right and still print different numbers for the same material.
So read the method line before the result line. If the document names a procedure, the number has a context you can reason about. If it does not, you are left with a figure whose conditions are unknown, and there is no way to compare it with anything.
What a supplier sample report can and cannot establish
A report supplied alongside material describes the sample that was submitted for testing. That is a real and useful record. It is not a statement about a different batch, a later production run, or the specific container in front of you, unless the lot identifiers line up and the document says so.
A supplier sample report describes the sample tested. It is not a verification of any other lot, and it should never be read as one.
This is why the lot field and the test date field do more work than their size on the page suggests. Without them, a report is an analysis of an anonymous sample.
What to ask a supplier for
Questions about documents are answerable in writing, which makes them the useful kind. All of the following ask for information a supplier either has or does not have.
- Which lot identifier the report belongs to, and whether that identifier appears on the material itself.
- The date the tests were run, not the date the document was produced.
- The analytical method used for each reported result, named specifically enough to be recognizable.
- Whether the purity figure is chromatographic area percent and whether net peptide content was measured separately.
- Whether identity was determined by mass spectrometry and what mass was observed against the expected mass.
- Whether the report is a sample report or a batch record, stated plainly.
An answer of no is still an answer. A document that does not exist is better known about in advance than assumed into existence.
What is missing when a field is absent
A missing lot number removes the link between the result and any specific material. A missing date removes the ability to judge how old the measurement is. A missing method reference removes the conditions. A missing content figure leaves the composition of the sample by weight unknown, however high the purity line reads.
Individual impurities are also a separate question from the total. High-resolution tandem mass spectrometry is what identifies and determines specific impurities in a peptide, where a chromatographic purity figure only reports the total remainder 5. A document reporting purity alone says how much is not the main peak, not what that material is.
How our listings handle documents
Listings on this site show a document link only where an approved document is on file for that listing. Where none is on file, the page says so rather than implying one exists. The documentation page describes the review process in full.
The listings below currently have a document available. Each card reads its name, vial content, price and availability from the live catalog record, and the document link appears only when a real file is registered for that listing.
Listings with a document on file
GHK-Cu
- Vial Content:
- 100 mg
BPC-157
- Vial Content:
- 10 mg
TB-500
- Vial Content:
- 10 mg
MOTS-C
- Vial Content:
- 10 mg
Semax
- Vial Content:
- 10 mg
PT-141
- Vial Content:
- 10 mg
RLP-IPA
- Vial Content:
- 10 mg
Glutathione
- Vial Content:
- 1500 mg
NAD+
- Vial Content:
- 500 mg
RLP-RT
- Vial Content:
- 30 mg
References
- 1. ICH Q6A, Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products (1999)
- 2. ICH Q2(R2), Validation of Analytical Procedures (2023)
- 3. Amino acid analysis for peptide quantitation using reversed-phase liquid chromatography combined with multiple reaction monitoring mass spectrometry (2023)
- 4. Chemiluminescent nitrogen detection as a new technique for purity assessment of synthetic peptides separated by reversed-phase HPLC (1996)
- 5. Impurity identification and determination for the peptide hormone angiotensin I by liquid chromatography-high-resolution tandem mass spectrometry and the metrological impact on value assignments by amino acid analysis (2013)
- 6. Characterization of Synthetic Peptides by Mass Spectrometry (2015)

